Sinobiomed, China Nonferrous Metals Resource Geological Survey Inc. deal

Sinobiomed divested its biopharmaceutical business, including subsidiary Wanxin Bio-Technology Ltd., to China Nonferrous Metals for $200,000. Wanxin's Chinese subsidiaries Shanghai Wanxing Bio-Pharmac...